142 related articles for article (PubMed ID: 15723717)
1. Evidence for a general cancer susceptibility locus at 3p24 in families with hereditary prostate cancer.
Chang BL; Gillanders EM; Isaacs SD; Wiley KE; Adams T; Turner AR; Zheng SL; Meyers DA; Carpten JD; Walsh PC; Trent JM; Xu J; Isaacs WB
Cancer Lett; 2005 Mar; 219(2):177-82. PubMed ID: 15723717
[TBL] [Abstract][Full Text] [Related]
2. Results of a genome-wide linkage analysis in prostate cancer families ascertained through the ACTANE consortium.
Edwards S; Meitz J; Eles R; Evans C; Easton D; Hopper J; Giles G; Foulkes WD; Narod S; Simard J; Badzioch M; Mahle L;
Prostate; 2003 Dec; 57(4):270-9. PubMed ID: 14601023
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.
Xu J; Gillanders EM; Isaacs SD; Chang BL; Wiley KE; Zheng SL; Jones M; Gildea D; Riedesel E; Albertus J; Freas-Lutz D; Markey C; Meyers DA; Walsh PC; Trent JM; Isaacs WB
Prostate; 2003 Dec; 57(4):320-5. PubMed ID: 14601028
[TBL] [Abstract][Full Text] [Related]
4. Early age at diagnosis in families providing evidence of linkage to the hereditary prostate cancer locus (HPC1) on chromosome 1.
Grönberg H; Xu J; Smith JR; Carpten JD; Isaacs SD; Freije D; Bova GS; Danber JE; Bergh A; Walsh PC; Collins FS; Trent JM; Meyers DA; Isaacs WB
Cancer Res; 1997 Nov; 57(21):4707-9. PubMed ID: 9354426
[TBL] [Abstract][Full Text] [Related]
5. Suggestive genetic linkage to chromosome 11p11.2-q12.2 in hereditary prostate cancer families with primary kidney cancer.
Johanneson B; Deutsch K; McIntosh L; Friedrichsen-Karyadi DM; Janer M; Kwon EM; Iwasaki L; Hood L; Ostrander EA; Stanford JL
Prostate; 2007 May; 67(7):732-42. PubMed ID: 17372923
[TBL] [Abstract][Full Text] [Related]
6. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.
Zuhlke KA; Madeoy JJ; Beebe-Dimmer J; White KA; Griffin A; Lange EM; Gruber SB; Ostrander EA; Cooney KA
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5975-80. PubMed ID: 15447980
[TBL] [Abstract][Full Text] [Related]
7. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX.
Lange EM; Chen H; Brierley K; Perrone EE; Bock CH; Gillanders E; Ray ME; Cooney KA
Clin Cancer Res; 1999 Dec; 5(12):4013-20. PubMed ID: 10632333
[TBL] [Abstract][Full Text] [Related]
8. A genomewide linkage analysis for prostate cancer susceptibility genes in families from Germany.
Maier C; Herkommer K; Hoegel J; Vogel W; Paiss T
Eur J Hum Genet; 2005 Mar; 13(3):352-60. PubMed ID: 15536476
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees.
Christensen GB; Camp NJ; Farnham JM; Cannon-Albright LA
Prostate; 2007 May; 67(6):605-13. PubMed ID: 17299800
[TBL] [Abstract][Full Text] [Related]
10. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.
Cunningham JM; McDonnell SK; Marks A; Hebbring S; Anderson SA; Peterson BJ; Slager S; French A; Blute ML; Schaid DJ; Thibodeau SN;
Prostate; 2003 Dec; 57(4):335-46. PubMed ID: 14601030
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide scan of Swedish families with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3.
Wiklund F; Gillanders EM; Albertus JA; Bergh A; Damber JE; Emanuelsson M; Freas-Lutz DL; Gildea DE; Göransson I; Jones MS; Jonsson BA; Lindmark F; Markey CJ; Riedesel EL; Stenman E; Trent JM; Grönberg H
Prostate; 2003 Dec; 57(4):290-7. PubMed ID: 14601025
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of SRD5A2 sequence variants in susceptibility to hereditary and sporadic prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Turner AR; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Prostate; 2003 Jun; 56(1):37-44. PubMed ID: 12746845
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide scan for linkage in finnish hereditary prostate cancer (HPC) families identifies novel susceptibility loci at 11q14 and 3p25-26.
Schleutker J; Baffoe-Bonnie AB; Gillanders E; Kainu T; Jones MP; Freas-Lutz D; Markey C; Gildea D; Riedesel E; Albertus J; Gibbs KD; Matikainen M; Koivisto PA; Tammela T; Bailey-Wilson JE; Trent JM; Kallioniemi OP
Prostate; 2003 Dec; 57(4):280-9. PubMed ID: 14601024
[TBL] [Abstract][Full Text] [Related]
14. Where are the prostate cancer genes?--A summary of eight genome wide searches.
Easton DF; Schaid DJ; Whittemore AS; Isaacs WJ;
Prostate; 2003 Dec; 57(4):261-9. PubMed ID: 14601022
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.
Hofer MD; Kuefer R; Maier C; Herkommer K; Perner S; Demichelis F; Paiss T; Vogel W; Rubin MA; Hoegel J
Cancer Res; 2009 Jan; 69(2):640-6. PubMed ID: 19147579
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics of prostate cancer in an analysis of linkage to four putative susceptibility loci.
Goode EL; Stanford JL; Peters MA; Janer M; Gibbs M; Kolb S; Badzioch MD; Hood L; Ostrander EA; Jarvik GP
Clin Cancer Res; 2001 Sep; 7(9):2739-49. PubMed ID: 11555587
[TBL] [Abstract][Full Text] [Related]
17. Description of the International Consortium For Prostate Cancer Genetics, and failure to replicate linkage of hereditary prostate cancer to 20q13.
Schaid DJ; Chang BL;
Prostate; 2005 May; 63(3):276-90. PubMed ID: 15599943
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.
Chang BL; Isaacs SD; Wiley KE; Gillanders EM; Zheng SL; Meyers DA; Walsh PC; Trent JM; Xu J; Isaacs WB
Prostate; 2005 Sep; 64(4):356-61. PubMed ID: 15754351
[TBL] [Abstract][Full Text] [Related]
19. Joint effect of HSD3B1 and HSD3B2 genes is associated with hereditary and sporadic prostate cancer susceptibility.
Chang BL; Zheng SL; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Carpten JD; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2002 Mar; 62(6):1784-9. PubMed ID: 11912155
[TBL] [Abstract][Full Text] [Related]
20. Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.
White KA; Lange EM; Ray AM; Wojno KJ; Cooney KA
Prostate Cancer Prostatic Dis; 2006; 9(3):298-302. PubMed ID: 16733518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
